Introduction {#Sec1}
============

Fracture is a common disease that has a great impact on patients' lives. Take Canada as an example, fractures and dislocations of the lower limb make up 38% of all injury admissions \[[@CR1]\]. It is estimated that the disability from traffic accidents (the major cause of fractures) will rank the top three of all causes of disability by 2020 \[[@CR2]\].

Fracture nonunion is one of the most common complications of fracture. The rate of fracture nonunion varies greatly in different anatomical locations of the fracture \[[@CR3]\], with an average incidence rate of 4.93% \[[@CR4]\]. Fracture nonunion is a chronic condition in terms of pain, and functional and psychosocial disability \[[@CR5]\]. Nonunion of some fractures can reduce the quality of life and even increase the risk of death \[[@CR3]\]. The cost of treatment for fracture nonunion was much more than that of fracture union \[[@CR6], [@CR7]\]. Other economic burdens caused by prolonged disability and downtime of job are more difficult to quantify but must be considered \[[@CR8]\].

Good blood supply is an important condition for fracture union \[[@CR1], [@CR9]\]. Compared to other long bones with abundant blood vessels and soft tissue, the tibia with a longer subcu**t**aneous boundary normally has a poorer blood supply \[[@CR10]\]. Therefore, tibial fracture has a higher risk of nonunion due to its special structure and blood supply. The definition of tibia fracture nonunion was no sign of union 9 months after surgical operation or no possibility of union if no further intervention was given assessed by surgeon \[[@CR11]\].

Doctors need to know how to predict the risk of fracture nonunion and set up a plan to reduce the rate of fracture nonunion \[[@CR8], [@CR12]\]. In 2007, the "diamond concept" was introduced by Giannoudis et al., aiming to define what is required to achieve adequate fracture healing. This concept highlights the importance of three biological factors (osteogenic cells, osteoconductive scaffolds, growth factors) and a fourth factor known as mechanical stabilization. If one or more of these factors are altered, adequate fracture healing will be threatened \[[@CR9], [@CR13], [@CR14]\].

Clinical and experimental studies have identified a number of potential factors that may help to predict fracture nonunion \[[@CR15]--[@CR18]\]. These factors include uncontrollable factors (for example, gender, age, underlying diseases, the way of injury) and controllable factors (for example, treatment method) \[[@CR19], [@CR20]\]. The uncontrollable factors of tibial nonunion may be similar to those of other anatomic sites. But there are too many influencing factors and even the same influencing factor may lead to different consequences in different anatomical positions \[[@CR21]\]. For controllable influencing factors, the treatment of tibial fracture is also controversial \[[@CR22]\]. Some doctors believe that intramedullary nailing (IMN) is the gold standard for the treatment of tibial fractures \[[@CR23], [@CR24]\]; however, most doctors consider that different treatment options have different advantages \[[@CR25]--[@CR28]\]. The use of non-steroidal anti-inflammatory drugs (NSAIDs) and the fixation of fibular fractures have also been considered as controversial factors for many years \[[@CR29], [@CR30]\].

Herein, we conducted a systematic review to explore the prevalence of nonunion in patients with tibia fracture and evaluate the association between influencing factors and tibia fracture nonunion. The study would provide valuable information for future prevention and treatment of tibia fracture nonunion.

Methods {#Sec2}
=======

Search strategy {#Sec3}
---------------

The PubMed, Cochrane Library, EMBASE, CNKI (China National Knowledge Infrastructure), Wanfang database, and Weipu database were systematically searched, from inception to June 2019. The search keywords were "tibia" AND \"fracture" AND "union OR nonunion OR disunion." The manual search was performed through checking the reference lists of key studies and review articles to identify additional studies.

Study selection {#Sec4}
---------------

An overall literature search was performed and relevant studies were screened independently by two reviewers (Ruifeng Tian, Fang Zheng). Initially, all the titles and abstracts which were identified based on the keywords were screened. Secondly, full texts of articles which were selected from the first phase were reviewed. Finally, the articles which had contents suitable for data extraction were included in the systematic review. Disagreements between the two reviewers were resolved by a third reviewer (Wei Zhao) via discussion and consensus.

Exclusion criteria {#Sec5}
------------------

Exclusion criteria were as follows: neither English nor Chinese; animal model experiment; patients at the age of \< 18; the cases of patients being lower than 10; insufficient information; duplicate publication; and obscure definition, such as delay union or mixed-descriptions of delay union and nonunion.

Data extraction {#Sec6}
---------------

Relevant data were extracted independently by two reviewers (Ruifeng Tian and Yuhui Zhang). Each of the following information was entered into a pre-designed form: first author's name, publication year, basic information of patients (including history of medication, unhealthy habits and basic diseases), fracture type, operative information, the number of all tibia fracture patients, and the number of tibia fracture nonunion patients. The information of 19 potentially influencing factors were also exacted for comparison analyses, including age, gender, tobacco smoke, drink, body mass index (BMI), diabetes, nonsteroidal anti-inflammatory drugs (NSAIDs) user, opioids user, osteofascial compartment syndrome, fracture site, injury energy (low or high energy that causes tibia fracture), open fracture, Gustilo-Anderson grade, Müller AO Classification of Fractures (AO), debride time (the time from injury to debride), open reduction, fibula fixation, infection, and fixation models. Disagreements between the two reviewers were resolved by a third reviewer (Jinping Yuan) via discussion and consensus.

Data analysis {#Sec7}
-------------

Stata software (v12.0, Stata Corp, College Station, TX, USA) was used to assess all statistical analyses and a *p \<* 0.05 was considered statistically significant. First, for exploring the prevalence of nonunion in patients with tibia fracture, the pooled prevalence and its 95% confidence intervals (CI) were calculated by using a random-effect model (*p* \< 0.05, *I*^2^ \> 50%), otherwise, or a fixed-effect model was selected (*p* \> 0.05, *I*^2^ \< 50%). When the prevalence rate in the included study was zero, double arcsine was used to deal with the data in case of data exclusion. Second, in the study of the association between potentially influencing factors and nonunion, the odds ratio (OR) and its 95% CI were calculated. To assess sources of heterogeneity, subgroup analyses were conducted, stratified by above 19 potentially influencing factors. Sensitivity analysis was performed by eliminating individual studies one by one. Publication biases were assessed by using the Begg's test and Egger's test.

Results {#Sec8}
=======

Characteristics of included studies {#Sec9}
-----------------------------------

A total of 3846 studies (2195 English and 1651 Chinese) were searched. Following selection process (Fig. [1](#Fig1){ref-type="fig"}), 111 studies were included in this systematic review and meta-analysis \[[@CR6], [@CR15], [@CR16], [@CR19], [@CR31]--[@CR136]\]. Fig. 1Flow diagram of the study selection process

These studies were published between 1997 and 2019 from USA, China, Australia, Belarus, Canada, Egypt, France, India, Iran, Italy, Japan, Malaysia, Singapore, Turkey, and UK. There were 46 studies written in English and 65 studies in Chinese. The number of patients with tibia fracture ranged from 30 to 14638, and the prevalence of tibia fracture nonunion ranged from 0 to 42.7%. The basic information in all included studies were listed in Table [1](#Tab1){ref-type="table"}. Table 1The basic information and prevalence of tibia fracture nonunion in each included studyAuthorYearCountryAgeMaleFemaleNumber of tibia fractureNumber of nonunionPrevalence[Su CA](https://www.ncbi.nlm.nih.gov/pubmed/?term=Su%20CA%5bAuthor%5d&cauthor=true&cauthor_uid=29778274) \[[@CR31]\]2018USA40.4225102284190.067[Mehta D](https://www.ncbi.nlm.nih.gov/pubmed/?term=Mehta%20D%5bAuthor%5d&cauthor=true&cauthor_uid=30035755) \[[@CR32]\]2018USA35.229114040.100[Milenkovic S](https://www.ncbi.nlm.nih.gov/pubmed/?term=Milenkovic%20S%5bAuthor%5d&cauthor=true&cauthor_uid=30382315) \[[@CR33]\]2018USA43.520123260.188Chang BS \[[@CR34]\]2018China23-5738266070.117Liu BQ \[[@CR35]\]2018China36.14655130.059Zhang JS \[[@CR36]\]2018China49.460349450.053Zhang QL \[[@CR37]\]2018China3550368600.000Yu JQ \[[@CR38]\]2018China42.465399450.053Jin PF \[[@CR39]\]2018China57.690107197260.132Ge Y \[[@CR40]\]2018China39.350429220.022Fang YS \[[@CR41]\]2018China45.249136210.016Li J \[[@CR42]\]2018China35.546397020.029Xu DY \[[@CR43]\]2018China40.938266430.047Li ZT \[[@CR44]\]2018China52.448429010.011[Dailey HL](https://www.ncbi.nlm.nih.gov/pubmed/?term=Dailey%20HL%5bAuthor%5d&cauthor=true&cauthor_uid=29664881) \[[@CR45]\]2018UK73926410031210.121[Singh A](https://www.ncbi.nlm.nih.gov/pubmed/?term=Singh%20A%5bAuthor%5d&cauthor=true&cauthor_uid=30078900) \[[@CR46]\]2018Singapore38.21012103440.427[Galal S](https://www.ncbi.nlm.nih.gov/pubmed/?term=Galal%20S%5bAuthor%5d&cauthor=true&cauthor_uid=29530513) \[[@CR47]\]2018Egypt37.25286020.033Javdan M\[[@CR48]\]2017USA231120.052[Auston DA](https://www.ncbi.nlm.nih.gov/pubmed/?term=Auston%20DA%5bAuthor%5d&cauthor=true&cauthor_uid=28169938) \[[@CR49]\]2017USA42184131315170.054[Zura R](https://www.ncbi.nlm.nih.gov/pubmed/?term=Zura%20R%5bAuthor%5d&cauthor=true&cauthor_uid=28377261) \[[@CR50]\]2017USA18-6362736535128089440.074[Thakore RV](https://www.ncbi.nlm.nih.gov/pubmed/?term=Thakore%20RV%5bAuthor%5d&cauthor=true&cauthor_uid=27658943) \[[@CR15]\]2017USA36364102486560.115[Chan DS](https://www.ncbi.nlm.nih.gov/pubmed/?term=Chan%20DS%5bAuthor%5d&cauthor=true&cauthor_uid=27763960) \[[@CR51]\]2017USA448232114240.211Xiong SR \[[@CR52]\]2017China42.5826614880.054[Javdan M](https://www.ncbi.nlm.nih.gov/pubmed/?term=Javdan%20M%5bAuthor%5d&cauthor=true&cauthor_uid=28620592) \[[@CR48]\]2017Iran35.94544930.061[BeytemürÔ](https://www.ncbi.nlm.nih.gov/pubmed/?term=Beytem%C3%BCr%20O%5bAuthor%5d&cauthor=true&cauthor_uid=27825761) \[[@CR53]\]2017Turkey40.652217310.014[Daolagupu AK](https://www.ncbi.nlm.nih.gov/pubmed/?term=Daolagupu%20AK%5bAuthor%5d&cauthor=true&cauthor_uid=28566781) \[[@CR54]\]2017India37.1432104230.071[Garg S](https://www.ncbi.nlm.nih.gov/pubmed/?term=Garg%20S%5bAuthor%5d&cauthor=true&cauthor_uid=28529014) \[[@CR55]\]2017India38.95313640.111Mukherjee S \[[@CR56]\]2017India40.326144030.075[Blair JA](https://www.ncbi.nlm.nih.gov/pubmed/?term=Blair%20JA%5bAuthor%5d&cauthor=true&cauthor_uid=26978131) \[[@CR57]\]2016USA42.215628184160.087[Burrus MT](https://www.ncbi.nlm.nih.gov/pubmed/?term=Burrus%20MT%5bAuthor%5d&cauthor=true&cauthor_uid=26553429) \[[@CR16]\]2016USA8132650614,63817580.120[Avilucea FR](https://www.ncbi.nlm.nih.gov/pubmed/?term=Avilucea%20FR%5bAuthor%5d&cauthor=true&cauthor_uid=26038037) \[[@CR58]\]2016USA40.616254216290.134[O\'Halloran K](https://www.ncbi.nlm.nih.gov/pubmed/?term=O'Halloran%20K%5bAuthor%5d&cauthor=true&cauthor_uid=27125823) \[[@CR19]\]2016USA39.393289382560.147[Barcakë](https://www.ncbi.nlm.nih.gov/pubmed/?term=Barcak%20E%5bAuthor%5d&cauthor=true&cauthor_uid=27101167) \[[@CR59]\]2016USA6450.078[Shen J](https://www.ncbi.nlm.nih.gov/pubmed/?term=Shen%20J%5bAuthor%5d&cauthor=true&cauthor_uid=27492066) \[[@CR60]\]2016China45547112500.000[Fang JH](https://www.ncbi.nlm.nih.gov/pubmed/?term=Fang%20JH%5bAuthor%5d&cauthor=true&cauthor_uid=27286045) \[[@CR61]\]2016China36.840165620.036Hao LS \[[@CR62]\]2016China19-6767158220.024Hu H \[[@CR63]\]2016China36.730225210.019Liu JQ \[[@CR64]\]2016China43.244166010.017Rao HR \[[@CR65]\]2016China35.735155020.040Bai T \[[@CR66]\]2016China36.843176040.067Zhao KP \[[@CR67]\]2016China35.641175810.017[Uchiyama Y](https://www.ncbi.nlm.nih.gov/pubmed/?term=Uchiyama%20Y%5bAuthor%5d&cauthor=true&cauthor_uid=29766068) \[[@CR68]\]2016Japan41.97788530.035[Gupta P](https://www.ncbi.nlm.nih.gov/pubmed/?term=Gupta%20P%5bAuthor%5d&cauthor=true&cauthor_uid=28435544) \[[@CR69]\]2016India42.72283010.033[Piątkowski K](https://www.ncbi.nlm.nih.gov/pubmed/?term=Pi%C4%85tkowski%20K%5bAuthor%5d&cauthor=true&cauthor_uid=26174055) \[[@CR70]\]2015USA49.5241745120.267Sun KF \[[@CR71]\]2015China43.1322011570.061Sun JQ \[[@CR72]\]2015China4835215670.125Ma N \[[@CR73]\]2015China45.4334246580820.141Huang H \[[@CR74]\]2015China17-6552449650.052Huang PZ \[[@CR75]\]2015China3243135610.018Zhang YH \[[@CR76]\]2015China36.549217020.029Luo BX \[[@CR77]\]2015China38.547317810.013Wang B \[[@CR78]\]2015China41.239337220.028Cui LH \[[@CR79]\]2015China37.553217420.027Meng YH \[[@CR80]\]2015China31.619355410.019Gong Y \[[@CR81]\]2015China16-39383270110.157Lian HK \[[@CR82]\]2015China35.151439440.043[Meena RC](https://www.ncbi.nlm.nih.gov/pubmed/?term=Meena%20RC%5bAuthor%5d&cauthor=true&cauthor_uid=25588847) \[[@CR83]\]2015India37.532124420.045[Sathiyakumar V](https://www.ncbi.nlm.nih.gov/pubmed/?term=Sathiyakumar%20V%5bAuthor%5d&cauthor=true&cauthor_uid=24770693) \[[@CR84]\]2014USA37.5633093170.183[Li Y](https://www.ncbi.nlm.nih.gov/pubmed/?term=Li%20Y%5bAuthor%5d&cauthor=true&cauthor_uid=24549966) \[[@CR85]\]2014China.43.3116512120.017Dai QH \[[@CR86]\]2014China34.523194200.000Wu ZH \[[@CR87]\]2014China48.532185010.020Li ZZ \[[@CR88]\]2014China43.876446050.083Ren Y \[[@CR89]\]2014China34.749217040.057Luan HX \[[@CR90]\]2014China37.178209860.061Zhang WJ \[[@CR91]\]2014China4443256830.044Heng WX \[[@CR92]\]2014China18-7945236840.059[Yavuz U](https://www.ncbi.nlm.nih.gov/pubmed/?term=Yavuz%20U%5bAuthor%5d&cauthor=true&cauthor_uid=24936840) \[[@CR93]\]2014Turkey4232235530.055[Lack WD](https://www.ncbi.nlm.nih.gov/pubmed/?term=Lack%20WD%5bAuthor%5d&cauthor=true&cauthor_uid=24990971) \[[@CR94]\]2014USA459271163130.080Berlusconi M \[[@CR95]\]2014Italy4542186050.083[Antonovaë](https://www.ncbi.nlm.nih.gov/pubmed/?term=Antonova%20E%5bAuthor%5d&cauthor=true&cauthor_uid=23351958) \[[@CR6]\]2013USA52.5378475853990.116Huang Q \[[@CR96]\]2013China36.9804012030.025Gong M \[[@CR97]\]2013China40.341115220.038Lv YM \[[@CR98]\]2013China39.1773411160.054Xu YD \[[@CR99]\]2013China391055816320.012[Clement ND](https://www.ncbi.nlm.nih.gov/pubmed/?term=Clement%20ND%5bAuthor%5d&cauthor=true&cauthor_uid=23997142) \[[@CR100]\]2013UK77.963170233230.099[Sitnik AA](https://www.ncbi.nlm.nih.gov/pubmed/?term=Sitnik%20AA%5bAuthor%5d&cauthor=true&cauthor_uid=23408177) \[[@CR101]\]2013Belarus4354268070.088[Yusof NM](https://www.ncbi.nlm.nih.gov/pubmed/?term=Yusof%20NM%5bAuthor%5d&cauthor=true&cauthor_uid=24643115) \[[@CR102]\]2013Malaysia24.552658100.172[Bishop JA](https://www.ncbi.nlm.nih.gov/pubmed/?term=Bishop%20JA%5bAuthor%5d&cauthor=true&cauthor_uid=23127455) \[[@CR103]\]2012USA3210.031Lin ZF \[[@CR104]\]2012China36.6222194416330.079Zhang H \[[@CR105]\]2012China39.658389610.010Jia QT \[[@CR106]\]2012China3661278840.045Zhou JL \[[@CR107]\]2012China5343952100.192[Rouhani A](https://www.ncbi.nlm.nih.gov/pubmed/?term=Rouhani%20A%5bAuthor%5d&cauthor=true&cauthor_uid=23153666) \[[@CR108]\]2012Iran26.44585430.056[Vallier HA](https://www.ncbi.nlm.nih.gov/pubmed/?term=Vallier%20HA%5bAuthor%5d&cauthor=true&cauthor_uid=21904230) \[[@CR109]\]2011USA38.3851911460.053Zhu DK \[[@CR110]\]2011China18-7653318430.036Zhao DL \[[@CR111]\]2011China37.854268010.013Liu F \[[@CR112]\]2011China32.632144640.087[Enninghorst N](https://www.ncbi.nlm.nih.gov/pubmed/?term=Enninghorst%20N%5bAuthor%5d&cauthor=true&cauthor_uid=21307734) \[[@CR113]\]2011Australia42.4662389260.292Xu JQ \[[@CR114]\]2009China36.31214917080.047Li ZG \[[@CR115]\]2009China35.8715612730.024Mahmudi N \[[@CR116]\]2009China3734104430.068Deng HP \[[@CR117]\]2009China40.351348540.047Dong JH \[[@CR118]\]2009China18-74775112820.016Fu KL \[[@CR119]\]2009China112110.098Zhou L \[[@CR120]\]2009China37.952419350.054Lang ZY \[[@CR121]\]2009China33.651166720.030Wu C \[[@CR122]\]2009China19-7125123720.054Li QM \[[@CR123]\]2009China37.61685121960.027[Yokoyama K](https://www.ncbi.nlm.nih.gov/pubmed/?term=Yokoyama%20K%5bAuthor%5d&cauthor=true&cauthor_uid=19753228) \[[@CR124]\]2008Japan34.6701484170.202[Aderinto J](https://www.ncbi.nlm.nih.gov/pubmed/?term=Aderinto%20J%5bAuthor%5d&cauthor=true&cauthor_uid=18450632) \[[@CR125]\]2008UK5430.056Lu HY \[[@CR126]\]2007China34.51589825690.035Hu GZ \[[@CR127]\]2007China33.4301116396110.028Zeng CJ \[[@CR128]\]2006China30.7390264541140.026Zhang YL \[[@CR129]\]2006China3573259890.092Zhao XZ \[[@CR130]\]2006China43.852267850.064Zhu GH \[[@CR131]\]2005China3455237850.064[Harris I](https://www.ncbi.nlm.nih.gov/pubmed/?term=Harris%20I%5bAuthor%5d&cauthor=true&cauthor_uid=16398806) \[[@CR132]\]2005Australia3412439163130.080[Cole PA](https://www.ncbi.nlm.nih.gov/pubmed/?term=Cole%20PA%5bAuthor%5d&cauthor=true&cauthor_uid=15475848) \[[@CR133]\]2004USA8920.022[Bonnevialle P](https://www.ncbi.nlm.nih.gov/pubmed/?term=Bonnevialle%20P%5bAuthor%5d&cauthor=true&cauthor_uid=13679742) \[[@CR134]\]2003France40.834154980.163[Harvey EJ](https://www.ncbi.nlm.nih.gov/pubmed/?term=Harvey%20EJ%5bAuthor%5d&cauthor=true&cauthor_uid=12650537) \[[@CR135]\]2002Canada110130.118[Keating J](https://www.ncbi.nlm.nih.gov/pubmed/?term=Keating%20JF%5bAuthor%5d&cauthor=true&cauthor_uid=9170379) \[[@CR136]\]1997USA11290.080

Pooled results, sensitive analysis, publication bias of the prevalence of tibia fracture nonunion {#Sec10}
-------------------------------------------------------------------------------------------------

Based on the results of random-effects method (*p \<* 0.05, *I*^2^ \> 50%), the prevalence of nonunion from tibia fracture patient was 0.068 (95% CI 0.060--0.077) (Fig. [2](#Fig2){ref-type="fig"}, Table [2](#Tab2){ref-type="table"}). The sensitive analysis demonstrated that there was no individual studies significantly affected the pooled results. The publication bias were found in pooled results (*t* = 3.19, *p* = 0.002) (Fig. [3](#Fig3){ref-type="fig"}). Fig. 2The forest plot of prevalence of tibia fracture nonunionTable 2The pooled results and subgroup analysis of prevalence of nonunion from tibia fracture patientNumber of study*Nn*Prevalence rateHeterogeneityModeleffect sizelower limitupper limit*I*^2^*p*Total1114142938170.0680.0600.07786.60%\< 0.01Random1. Age (year)\< 603545600.1250.0600.18977.50%0.012Random\> 603316650.2040.1600.2490.00%0.689Fixed2. GenderMale1181867900.1310.1040.15977.80%\< 0.01RandomFemale1181236180.1180.0850.15084.50%\< 0.01Random3. Tobacco smokerYes822632990.1730.1190.22691.80%\< 0.01RandomNo8121778880.1110.0720.15087.30%\< 0.01Random4. DrinkYes2348420.1360.0360.23582.50%0.017RandomNo2128429580.0980.0430.15286.90%0.006Random5. Body mass index\< 3022446622570.0910.0490.13399.30%\< 0.01Random\> 30237904510.1190.1090.1290.00%0.557Fixed30--40225072360.0940.0830.1050.00%0.441Fixed\< 4022697324930.0910.0530.12899.20%\< 0.01Random\> 40212832150.1600.0200.21887.80%0.004Random6. DiabetesYes4347730.2210.1780.2678.50%0.335FixedNo49841030.1020.0650.13967.50%0.046RandomYes3371580.1530.1160.1890.00%0.420FixedNo311971440.1170.0990.13559.90%0.083Random8. Opioids userYes310351450.1400.1180.1610.00%0.694FixedNo3522580.0970.0310.16478.40%0.010Random9. Fracture siteProximal7586300.0430.0270.0626.50%0.254FixedMiddle77241150.1460.0800.21184.60%\< 0.01RandomDistal7614880.1390.1040.17824.10%0.253Fixed10. Injury energyHigh47101050.1490.0830.24183.60%\< 0.01RandomLow4298220.0650.0070.17587.30%\< 0.01Random11.Open fractureYes10140379160.0620.0490.07456.20%0.015RandomOn1019853900.1970.1450.29484.80%\< 0.01Random12. Gustilo-Anderson grade^a^I or II9680570.0700.0510.08931.30%0.168FixedIIIA9394550.1300.0970.1630.00%0.686FixedIIIB or IIIC9220890.3820.1980.56688.90%\< 0.01random13.Müller AO Classification of Fractures (AO) classification^b^A71039690.0590.0270.09068.90%0.004RandomB76001030.1400.0860.20465.90%0.007RandomC7285540.1580.0780.26074.50%0.001Random14. Debride time\< 6 h2138410.3020.0740.53089.10%0.002Random\> 6 h249200.4050.2680.5410.00%0.411Fixed15. Open reductionYes9573480.0750.0430.10752.40%0.032RandomNo9606260.0430.0280.06042.10%0.086Fixed16. Fixation mode^c^ORIF4162167030.0810.0580.10782.10%\< 0.01RandomIMN511264213260.0540.0400.07077.30%\< 0.01RandomMIPPO25988180.0230.0150.0320.00%0.835FixedExternal fixation680330.0550.0230.09876.90%\< 0.01RandomConservative treatment4116220.1340.0030.40992.10%\< 0.01Random17. Fibula fixedYes7166110.0730.0270.14053.20%0.046RandomNo7538690.1220.0940.149\< 0.010.611Fixed18. Osteofascial compartment syndromeYes3210310.1340.0880.17961.90%0.072FixedNo313591620.1050.0580.15185.40%0.001Random19. InfectionYes2217840.5100.1550.86693.80%\< 0.01RandomNo213661190.0760.0220.12992.80%\< 0.01Random^a^Gustilo-Anderson classification: grade I: clean wound \< 1 cm in length; grade II: wound 1--10 cm in length without extensive soft-tissue damage, flaps or avulsions; grade III: extensive soft-tissue laceration (\>10 cm) or tissue loss/damage or an open segmental fracture; grade IIIa: adequate periosteal coverage of the fracture bone despite the extensive soft-tissue laceration or damage; grade IIIb: extensive soft-tissue loss, periosteal stripping and bone damage, usually associated with massive contamination; grade IIIc: associated with an arterial injury requiring repair, irrespective of degree of soft-tissue injury^b^AO classification of tibia fractures with designations of A: simple, B: wedge, C: complex^c^*ORIF* open reduction and internal fixation, *IMN* intramedullary nailing, *MIPPO* minimally invasive plate osteosynthesisFig. 3The publication bias of prevalence of tibia fracture nonunion

Subgroup analysis of prevalence of tibia fracture nonunion and comparison results {#Sec11}
---------------------------------------------------------------------------------

The prevalence of tibia fracture nonunion in different countries were of various (Tables [2](#Tab2){ref-type="table"}, [3](#Tab3){ref-type="table"}, and [4](#Tab4){ref-type="table"}), for example, USA was 0.094 (95% CI 0.075--0.114), China was 0.047 (95% CI 0.039--0.057), etc. Table 3The comparison results stratified by 19 influencing factorsStudyComparison resultsHeterogeneityModel*p*ORlower limitupper limit*I*^2^*p*1. Age (year)\> 60 vs. \< 603\< 0.052.6021.6864.01648.70%0.142Fixed2. GenderMale vs. Female11\< 0.051.2561.1221.40714.00%0.311Fixed3. Tobacco smokerYes vs*.* No8\< 0.051.6921.4581.96449.30%0.055Fixed4. DrinkYes vs. No20.0831.3670.9601.9470.00%0.518Fixed5. Body mass index (BMI)30 \< BMI \< 40 vs. BMI \< 3020.8011.0850.5752.05093.70%\< 0.05RandomBMI \> 40 vs. BMI \< 302\< 0.051.8741.6072.1850.00%0.660FixedBMI \> 30 vs. BMI \< 3020.1891.3510.8622.11993.00%\< 0.05RandomBMI \> 40 vs. 30 \< BMI \< 4020.0451.7731.0143.10284.30%0.012RandomBMI \> 40 vs. BMI \< 402\< 0.051.8991.6302.2120.00%0.892Fixed6. DiabetesYes vs. No3\< 0.052.7311.8574.01432.20%0.229Fixed7. Nonsteroidal anti-inflammatory drugs userYes vs. No30.0181.5361.0762.1940.00%0.384Fixed8. Opioids userYes vs. No30.0122.0101.1663.4680.00%0.370Fixed9. Fracture siteMiddle vs. Proximal7\< 0.053.1522.0194.9220.00%0.788FixedDistal vs. Proximal7\< 0.052.8771.8224.5430.00%0.911FixedDistal vs. Middle70.6700.9320.6731.2900.00%0.650Fixed10. Injury energyHigh vs. Low40.0012.6021.4844.56235.90%0.182Fixed11. Open fractureYes vs. No9\< 0.052.8461.7004.20216.50%0.296Fixed12. Gustilo-Anderson grade^a^IIIA vs. I or II90.0051.8311.2042.7840.00%0.847FixedIIIB or IIIC *vs.* I or II9\< 0.057.2024.78110.8484.60%0.394FixedIIIB or IIIC *vs.* IIIA9\< 0.053.6952.4225.63932.60%0.168Fixed13. Müller AO Classification of Fractures (AO) classification^b^B *vs.* A70.0102.5221.2495.93054.20%0.041RandomC *vs.* A7\< 0.053.6852.4055.64837.00%0.160FixedC *vs.* B7\< 0.053.5692.4285.32539.60%0.142Fixed14. Debride time\< 6 h vs. \> 6 h20.6311.1900.5852.4190.00%0.520Fixed15. Open reductionYes vs. No9\< 0.052.8871.7154.86126.20%0.220Fixed16. Fixation mode^c^IMN vs. MIPPO150.0032.6811.3975.1460.00%0.980FixedIMN vs. ORIF280.0201.1271.0191.24754.10%\<0.05RandomORIF vs. MIPPO70.0103.4951.3519.0450.00%0.859FixedExternal vs. ORIF100.1150.5060.2171.18254.00%0.016RandomConservative vs. ORIF40.2641.4960.7373.03564.10%0.062FixedExternal vs. IMN100.9931.0060.2663.80655.40%0.022Random17. Fibula fixedYes vs. No70.4351.3170.6592.63447.60%0.075Random18. Osteofascial compartment syndromeYes vs. No30.1061.4200.9682.17380.30%0.006Fixed19. InfectionYes vs. No2\< 0.0511.8777.46118.90652.10%0.149Fixed^a^Gustilo-Anderson classification: grade I: clean wound \< 1 cm in length; grade II: wound 1--10 cm in length without extensive soft-tissue damage, flaps or avulsions; grade III: extensive soft-tissue laceration (\> 10 cm) or tissue loss/damage or an open segmental fracture; grade IIIa: adequate periosteal coverage of the fracture bone despite the extensive soft-tissue laceration or damage; grade IIIb: extensive soft-tissue loss, periosteal stripping and bone damage, usually associated with massive contamination; grade IIIc: associated with an arterial injury requiring repair, irrespective of degree of soft-tissue injury^b^AO classification of tibia fractures with designations of A: simple, B: wedge, C: complex^c^*ORIF* open reduction and internal fixation, *IMN* intramedullary nailing, *MIPPO* minimally invasive plate osteosynthesisTable 4Prevalence of nonunion from tibia fracture in different countriesNumber of study*Nn*Prevalence rateHeterogeneityModelEffect sizeLower limitUpper limit*I*^2^*p*USA193016730830.0940.0750.11493.40%\< 0.01RandomChina6875503960.0470.0390.05769.50%\< 0.01RandomAustralia2252390.1820.0260.38993.90%\< 0.01RandomBelarus18070.088----------Canada1110130.118----------Charlotte1163130.08----------Egypt16020.033----------France14980.162----------India5150100.0590.0260.09200.73FixedIran315290.0590.0220.09700.99FixedItaly16050.083----------Japan2169200.1140.0490.27891.70%0.001RandomMalaysia158100.172----------Singapore1103440.427----------Turkey17310.014----------UK410421560.1080.0920.12447.60%0.126Fixed

In the following comparisons of influencing factors (Table [3](#Tab3){ref-type="table"}), each of the former prevalence of tibia fracture nonunion was significantly higher than the latter one (*p* \< 0.05), i.e., \> 60 years old (0.204) vs. \< 60 years old (0.125), male (0.131) vs. female (0.118), tobacco smoker (0.173) vs. non-smoking (0.111), BMI \> 40 (0.160) vs. BMI \< 40 (0.091), diabetes (0.221) vs. no diabetes (0.102), NSAIDs user (0.153) vs. none NSAIDs user (0.117), opioids user (0.140) vs. none opioids user (0.097), fracture of middle segment (0.146) vs. proximal segment (0.043), fracture of distal segment (0.139) vs. proximal segment (0.043), high-energy injury (0.149) vs. low-energy injury (0.065), open fracture (0.197) vs. close fracture (0.062), Gustilo-Anderson grade I or II (0.070) vs. IIIA (0.130) vs. IIIB and IIIC (0.382), AO Classification A (0.059) vs. B (0.140) vs. C (0.158), open reduction (0.075) vs. close reduction (0.043), infection (0.510) vs. without infection (0.076). No significant difference was found between other comparisons (*p* \> 0.05).

There were 5 fixation models of tibial fractures available, including open reduction and internal fixation (ORIF), intramedullary nailing (IMN), minimally invasive percutaneous plate osteosynthesis (MIPPO), external fixation, and conservative treatment. Significant difference was found between each other comparison of the following 3 fixation models, ORIF (0.081) vs. IMN (0.054) vs. MIPPO (0.023) (*p* \< 0.05) (Fig. [4](#Fig4){ref-type="fig"}). No significant difference was found between external and ORIF, conservative and ORIF, or external and IMN (*p* \> 0.05). Fig. 4The comparison of MIPO with IMN

Discussion {#Sec12}
==========

To our knowledge, this is the first systematic review and meta-analysis to estimate the prevalence of nonunion in patients with tibia fracture and the relationship between different influence factors and tibia fracture nonunion. The pooled prevalence of tibial fracture nonunion was 0.068. Different countries were in variety of prevalence, indicating a heredity disparity. The lowest prevalence was seen in Turkey (0.014) and next was Egypt (0.033); however, the numbers of included studies were so small that the conclusions were not so robust. There were 68 studies that were conducted in China involving 7550 tibia fracture patients and the prevalence of nonunion was 0.047. However, one study in Singapore, a country that has lots of Chinese population, presented a very high prevalence of tibia fracture nonunion 0.427, indicating other influencing factors other than heredity. In calendar year 2011, an inception cohort study in a large payer database of patients with fracture in the USA was conducted using patient-level health claims for medical and drug expenses compiled for approximately 12,808 patients, and the prevalence of tibial fracture nonunion was reported to be 0.074 \[[@CR137]\]. In contrast, the present systematic review involved 30,167 patients in a total of 19 studies conducted in the USA and the prevalence was 0.094. The pooled results enabled a larger sample size and accessed more to the real conclusion.

Some influencing factors contributed to the nonunion of tibial fractures. In 2016, O\'Halloran K et al. created a Nonunion Risk Determination Score (NURDS) to predict nonunion risk, based on 7 influencing factors (*p* \< 0.05, OR \> 2), including flaps, compartment syndrome, chronic condition(s), open fractures, male gender, grade of American Society of Anesthesiologists Physical Status, and percent cortical contact. While another 2 factors including spiral fractures and low-energy injuries can be predictive of union \[[@CR19]\]. In our study, we found more influencing factors, including age \> 60 years old, diabetes, opioids user, middle and distal fracture, high-energy injury, open fracture, Gustilo-Anderson grade IIIB and IIIC, and AO Classification C met above criteria (*p* \< 0.05, OR \> 2) and can be regarded as predictive indicators. Still, there were some other influencing factors, including male, tobacco smoker, BMI \> 40, and NSAIDs user, partially predicated the risks (*p* \< 0.05, OR \< 2).

The present study showed that BMI \> 40 and diabetes were the influencing factors of nonunion of tibia fractures. With the improvement of quality of life, the negative impact of obesity has gradually become a hot issue of concern. Obesity can lead to vitamin D deficiency, and whether there is a causal relationship between fracture nonunion and vitamin D deficiency is the focus of discussion \[[@CR138], [@CR139]\]. But we cannot ignore the fact that diabetes mellitus is closely related to obesity. In our study, the use of NSAIDs was also associated with fracture nonunion. Some experiments have proved that NSAIDs can temporarily inhibit the process of fracture union \[[@CR140], [@CR141]\]; however, other studies considered that the pain caused by fracture nonunion of patients led to their resorting to NSAIDs \[[@CR142]\].

Our comparison showed that open reduction had a higher rate of fracture nonunion than closed reduction. In surgery, although open reduction can bring good fracture repair, but closed reduction can better protect blood supply and soft tissue. In addition, our study did not find a relationship between fibular fixation and nonunion rates of tibial fractures. However, Strauss EJ and Kumar A' experiments on cadavers showed that fibular fixation can increase the stability of tibial fractures after surgery \[[@CR143]--[@CR145]\]. So whether it is necessary to fix the fibula for the treatment of tibial fracture accompanied by fibular fracture should be further determined.

The choice of fixation mode is a way to control the nonunion rate of tibial fracture artificially \[[@CR146], [@CR147]\]. We compared 5 fixation modes available. The nonunion rate of conservative treatment was the highest one compared with that of surgical treatment. This is obviously different from the lowest rate reported by Li H et al. \[[@CR148]\]. This may be related to the insufficient number of articles in conservative treatment. Compared with traditional ORIF, IMN and MIPPO have lower fracture nonunion rate. No significant difference was found between external fixation and ORIF. Ebraheim NA et al. reported that IMN can achieve better healing effect in the treatment of tibial fractures, comparing to ORIF and external fixation \[[@CR149]\]. MIPPO had the lowest nonunion rate of all fixation modes. It was proved that MIPPO can maximize the protection of soft tissue and bone marrow around the fracture site \[[@CR150]\]. The above 5 fixation modes destroy the necessary conditions of fracture healing to varying degrees. However, it is worth mentioning that different options have different advantages in the treatment of tibial fractures \[[@CR151], [@CR152]\]. For example, in distal tibial fractures, more comminuted fractures would rather require open reduction than "simple" type A fractures. So it is unreasonable to only consider the nonunion rate of fracture of operation \[[@CR148]\].

The systematic review and meta-analysis had made strict inclusion and exclusion criteria, but still had some limitations and bias which may be unavoidable. Firstly, due to different attentions of individual studies, the influencing factors were only extracted from partial studies with available data and some other influencing factors such as hemoglobin and bone defect were not mentioned. Secondly, different doctors and different hospitals had a variety of surgical technologies and conditions, which may cause unavoidable bias. Thirdly, the number of included studies and the data for meta-analysis were limited which may affect the final results to a certain degree. Fourthly, publication bias was found in the study. Therefore, the data from literature in other languages, more areas, and ongoing studies are required to reflect a more accurate and wide variation. Finally, non-randomized controlled trials (nRCTs) were involved in this systematic review. As a result, subjective factors may affect the result. More rigorous designs and large RCTs are required to make further verification.

In conclusion, the prevalence of nonunion in patients with tibia fracture was 0.068 and 15 potential factors were associated with the prevalence. Closed reduction and MIPPO have low risks of nonunion for the treatment of tibial fractures. A series of factors shed the light which may affect the union rate of tibial fracture for doctors' reference, and provide the probability of nonunion of tibial fracture under different treatment schemes. The authors hope to help doctors assess the risk of nonunion and propose the most suitable treatment for patients with tibial fractures under different conditions.

CNKI

:   China National Knowledge Infrastructure

OR

:   Odds ratio
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MIPPO

:   Minimally invasive percutaneous plate osteosynthesis

IMN

:   Intramedullary nailing

NRCTs
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